homepage image

Brain Health

MindMed works to improve patient outcomes through our pipeline of novel drug candidates and digital therapeutics.


MindMed to Participate in the TD Cowen 3rd Annual Novel Mechanisms in Neuropsychiatry Summit

We strive to deliver on the therapeutic potential of psychedelics and other novel compounds to address unmet patient needs in the fields of psychiatry, addiction, pain and neurology.

1-year prevalence of anxiety disorders in the US
Estimated prevalence among US adults
Autism Spectrum Disorder
Economic cost of ASD in the US predicted by 2025

A Global Leader in Brain Health

MindMed uses industry-leading drug development expertise in its mission to unlock the full therapeutic potential of psychedelics and other novel therapeutic targets.

Research & Development Pipeline

Our pipeline offers opportunities across diverse therapeutic areas and mechanisms of action

Explore MindMed’s R&D Programs to learn more about the opportunities that exist to advance novel treatments for a wide range of brain health disorders.